Triple Negative Breast Cancer News and Research

RSS

Australian researchers uncover a promising new way to tackle triple-negative breast cancer

Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.

21 Aug 2026

LIG1 loss reveals new treatment strategy for aggressive breast cancer

Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers at Baylor College of Medicine and collaborating institutions have identified a vulnerability in these cells and used it to their advantage.

16 Jul 2026

Researchers at Tulane University School of Medicine strengthen breast cancer research workflows with advanced liquid handling

Advanced liquid handling tools from INTEGRA Biosciences are transforming breast cancer research at Tulane, boosting accuracy and workflow efficiency in the lab.

From INTEGRA Biosciences 9 Jul 2026

Researchers at Tulane University School of Medicine strengthen breast cancer research workflows with advanced liquid handling

A laboratory at the Tulane University School of Medicine has enhanced its drug screening and tumor modelling workflows by adopting advanced liquid handling solutions from INTEGRA Biosciences, including the PIPETBOY GENIUS serological pipet controller and VIAFLO electronic pipettes.

From Tulane University School of Medicine 17 Jun 2026

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug discovery, today announced the formation of its Scientific Advisory Board (SAB), appointing John Lambert as Chair, with Morris Rosenberg and Peter de Waele serving alongside.

From VALANX Biotech 15 Apr 2026

Princeton researchers reveal new links between high-fat diets and aggressive breast cancer

Princeton researchers have revealed new links between high-fat diets and aggressive breast cancer, demonstrating the important role fat plays in making some cancers more invasive.

6 Apr 2026

Triple negative breast cancer cells use new strategy to boost metastatic ability

Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.

6 Feb 2026

New markers improve detection of aggressive breast cancer cells in the blood

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

16 Jan 2026

Study identifies PUF60 as a critical vulnerability in triple negative breast cancer

Researchers at University of California San Diego have identified a previously unrecognized treatment target for triple‑negative breast cancer (TNBC), the most aggressive subtype of breast cancer.

12 Jan 2026

Researchers discover how aggressive breast cancer controls protein production

A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its production of proteins has been discovered by researchers at Umeå University, Sweden.

12 Jan 2026

Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.

7 Jan 2026

Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive subtype of triple-negative breast cancer.

26 Dec 2025

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

11 Dec 2025

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies.

5 Dec 2025

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer.

4 Dec 2025

Hematological and biochemical indicators show growing value in breast cancer management

Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality.

27 Nov 2025

Study reveals biological insights into triple negative breast cancer

Researchers at the LSU LCMC Health Cancer Center have published groundbreaking findings in NPJ Breast Cancer that sheds new light on triple-negative breast cancer (TNBC), one of the most aggressive forms of breast cancer.

24 Nov 2025

Marine bacterium shows powerful therapeutic effects against colorectal cancer

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine bacterium Photobacterium angustum demonstrates remarkable therapeutic efficacy against colorectal cancer.

21 Nov 2025

Novel therapy reduces tumor growth in models of triple-negative breast cancer

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.

18 Nov 2025

Long non-coding RNA MALAT1 linked to progression and spread of triple-negative breast cancer

When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in cancer's development or spread.

11 Nov 2025

Triple Negative Breast Cancer News and Research

Australian researchers uncover a promising new way to tackle triple-negative breast cancer

LIG1 loss reveals new treatment strategy for aggressive breast cancer

Researchers at Tulane University School of Medicine strengthen breast cancer research workflows with advanced liquid handling

Researchers at Tulane University School of Medicine strengthen breast cancer research workflows with advanced liquid handling

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

Princeton researchers reveal new links between high-fat diets and aggressive breast cancer

Triple negative breast cancer cells use new strategy to boost metastatic ability

New markers improve detection of aggressive breast cancer cells in the blood

Study identifies PUF60 as a critical vulnerability in triple negative breast cancer

Researchers discover how aggressive breast cancer controls protein production

Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer

Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

Hematological and biochemical indicators show growing value in breast cancer management

Study reveals biological insights into triple negative breast cancer

Marine bacterium shows powerful therapeutic effects against colorectal cancer

Novel therapy reduces tumor growth in models of triple-negative breast cancer

Long non-coding RNA MALAT1 linked to progression and spread of triple-negative breast cancer

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News